Roth Mkm reiterated their buy rating on shares of Celsius (NASDAQ:CELH – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $38.00 price target on the stock.
Several other research firms have also recently commented on CELH. Deutsche Bank Aktiengesellschaft initiated coverage on Celsius in a research note on Thursday, December 12th. They set a “hold” rating and a $32.00 target price for the company. B. Riley reissued a “buy” rating and issued a $49.00 price objective (up previously from $44.00) on shares of Celsius in a research note on Friday. Piper Sandler dropped their target price on Celsius from $47.00 to $33.00 and set an “overweight” rating on the stock in a report on Thursday, January 23rd. Jefferies Financial Group dropped their target price on Celsius from $44.00 to $40.00 and set a “buy” rating on the stock in a report on Thursday, December 19th. Finally, TD Cowen lowered Celsius from a “buy” rating to a “hold” rating and dropped their target price for the company from $40.00 to $29.00 in a report on Wednesday, January 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Celsius presently has an average rating of “Moderate Buy” and a consensus target price of $47.67.
Read Our Latest Stock Analysis on CELH
Celsius Trading Up 27.8 %
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.03. Celsius had a return on equity of 59.40% and a net margin of 15.61%. The company had revenue of $332.20 million during the quarter, compared to analysts’ expectations of $326.07 million. Sell-side analysts forecast that Celsius will post 0.67 earnings per share for the current year.
Insider Activity
In other news, major shareholder William H. Milmoe sold 65,000 shares of Celsius stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $31.15, for a total value of $2,024,750.00. Following the completion of the transaction, the insider now directly owns 261,245 shares in the company, valued at approximately $8,137,781.75. The trade was a 19.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.
Hedge Funds Weigh In On Celsius
Hedge funds have recently made changes to their positions in the stock. Champlain Investment Partners LLC purchased a new position in Celsius during the fourth quarter worth about $85,068,000. Contrarius Group Holdings Ltd purchased a new position in Celsius during the fourth quarter worth about $75,535,000. Norges Bank purchased a new position in Celsius during the fourth quarter worth about $72,579,000. Alyeska Investment Group L.P. grew its position in Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock worth $181,164,000 after buying an additional 2,591,345 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Celsius during the fourth quarter worth about $61,160,000. 60.95% of the stock is currently owned by hedge funds and other institutional investors.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Roth IRA Calculator: Calculate Your Potential Returns
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Stock Average Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.